Sumitomo Chemcl (OTCMKTS:SOMMY) Shares Down 3.3% - Here's Why

Key Points

• Shares of Sumitomo Chemical (OTCMKTS:SOMMY) declined by 3.3% during mid-day trading, closing at $15.69.
• The company's recent earnings report revealed a loss of ($0.10) earnings per share (EPS) and revenue of $3.64 billion for the quarter.
• Sumitomo Chemical has a market capitalization of $5.20 billion and a price-to-earnings ratio of 92.29.

Sumitomo Chemcl (OTCMKTS:SOMMY - Get Free Report) shares traded down 3.3% during mid-day trading on Tuesday . The company traded as low as $15.69 and last traded at $15.69. 416 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 1,728 shares. The stock had previously closed at $16.23.

Sumitomo Chemcl Stock Performance

The company has a current ratio of 1.56, a quick ratio of 0.89 and a debt-to-equity ratio of 0.97. The stock has a fifty day moving average price of $14.21 and a 200-day moving average price of $12.63. The firm has a market capitalization of $5.20 billion, a price-to-earnings ratio of 92.29 and a beta of 0.25.

Sumitomo Chemcl (OTCMKTS:SOMMY - Get Free Report) last issued its earnings results on Friday, August 1st. The company reported ($0.10) earnings per share (EPS) for the quarter. Sumitomo Chemcl had a return on equity of 0.80% and a net margin of 0.35%.The company had revenue of $3.64 billion during the quarter.

Sumitomo Chemcl Company Profile

Sumitomo Chemical Company, Limited engages in Chemicals & Plastics, energy and functional materials, IT-related chemicals, health and crop sciences, pharmaceuticals, and other businesses worldwide. Its Essential Chemicals & Plastics segment offers synthetic resins, such as polyethylene, polypropylene, and polymethyl methacrylate resins; raw materials for synthetic fibers; and various industrial chemicals.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.